Introduction {#s1}
============

Recently published ethnopharmacological studies regarding the genus *Cornus* (Cornaceae) have shown that among 65 species only two of them have a long tradition in a medicinal use. *Cornus mas* L. native to southern Europe and southwest Asia, known as cornelian cherry, is used since ancient times (Dragendorff, [@B39]). The fruits of this plant were used for a broad variety of diseases and complaints in all areas of its geographical distribution. The preparations from *C. mas* (European cornel, cornelian cherry) were considered as astringent, tonic and antipyretic remedies (Fournier, [@B49]). *Cornus officinalis* Sieb. et Zucc., also named Asiatic dogwood (cornel dogwood, Japanese cornel), is a deciduous tree distributed in eastern Asia, mainly in China, as well as Korea and Japan (Ma et al., [@B114]). It was used as a traditional Chinese medicine for more than 2,000 years to promote a healthy liver and kidney, and is a common ingredient of many TCM prescriptions (Liu X. et al., [@B109]).

The dogwood genus *Cornus* L. is a member of Cornales in the Asterids clade (The Angiosperm Phylogeny Group; APG IV, [@B5]). The dogwood genus is morphologically heterogenous, variable in inflorescences, fruits and chromosomes (Eyde, [@B46]; Xiang et al., [@B180]; Ma et al., [@B113]). Four major lineages of the dogwood genus *Cornus* L., such as the blue- or white-fruited group, the cornelian cherry group, the big-bracted group and the dwarf dogwood group, have been drawn (Xiang et al., [@B183], [@B184]). However, the systematical classification of flowering plants from Cornales clade and relationships within this taxon seems to be problematic for many years (Xiang et al., [@B179], [@B182], [@B181], [@B183]; Fan and Xiang, [@B47]; APG IV, [@B5]). Despite these controversies, phylogenetic analyses of this clade based on four DNA regions, such as *rbcL* and *matK* from chloroplast DNA genome as well as 26S rDNA and ITS (internal transcribed spacer) 1--5. 8S rDNA from the nuclear genome, classified both *C. mas* and *C. officinalis* in the group of cornelian cherries (Xiang et al., [@B182], [@B181], [@B183]; Fan and Xiang, [@B47]). In addition, the subgenera *Afrocarnia* (Harms) Wangerin, *Cornus* L. and *Sinocornus* Q.Y. Xiang were included into the group of cornelian cherries. *Cornus mas* and *C. officinalis* were classified in the subgenus *Cornus* L. (Fan and Xiang, [@B47]; Xiang et al., [@B183]). Both of them are temperate deciduous small shrubs or trees blooming before leaf development. The morphological characters, such as umbellate cymes terminal subtended by four not showy scale-like bracts, red or purple black fruits and the wall of fruit stone riddled with cavities, supported the membership of these species in the monophyletic group of cornelian cherries. All these data strongly supported the sister phylogenetic relationship of *C. mas* and *C. officinalis* (Xiang et al., [@B180]). The genus *Cornus* is widely distributed in the northern hemisphere. Fossil fruit stones similar to the contemporary fruit stones of *C. mas* are likely to derive from the late Miocene of Poland, as well as from Pliocene and Pleistocene of France, Germany and Netherlands. Evidence from analyses of fossils, phylogeny and biogeographic distribution support an origin and early diversification of *Cornus* likely in Europe. It is suggested that the ancestor of the living cornelian cherries spread from Europe to eastern Asia around the mid-Oligocene and the mid-Miocene. *Cornus mas* is a single representative species of cornelian cherry in Europe. On the other hand, *C. officinalis* in eastern Asia represents the Miocene migrant from Europe (Xiang et al., [@B180]). Based on the different geographic distribution of the closely related species but clearly distinct taxa, the ethnopharmacological use of *C. mas* and *C. officinalis* seems to be independently originated. In the traditional medicine of Europe and Middle East only fruits of *C. mas* were used and in the traditional medicine of China reports describe only preparations of fruits from *C. officinalis* for medicinal application.

Plant materials belonging to the genus *Cornus* are characterized by the presence of secondary metabolites, in particular iridoids, anthocyanins, tannins and flavonoids. Although many reports on the quality of fruits of *C. mas* were performed due to the fact of their value as edible fruits, as well as few studies compared their properties with other edible fruits used for a production of wines, liquors or jams (Tarko et al., [@B163]; Cosmulescu et al., [@B31]), the detailed phytochemical profiles of *C. mas* and *C. officinalis*, in particular fruits, have never been compared. The chemical composition of plant materials obtained from *C. mas* and *C. officinalis* can be significantly different depending on the geographic location, climatic factors, season, as well as cultivation practice. For this reason, the phytochemical composition is considered an important factor determining the biological activity and justifying the traditional use of these species.

All these facts taking together make interesting to compare the therapeutic use of both traditional species based on their chemical composition. This review particularly highlights the similarities and differences in phytochemicals found in fruits of *C. mas* and *C. officinalis* in relation to their biological effects based on reports available in this field.

Similarities and differences in the chemical composition of fruits from *C. mas* and *C. officinalis* {#s2}
=====================================================================================================

General
-------

The main secondary metabolites found in dogwoods seem to be iridoid and non-flavonoid glucosides. Even though the blue-fruited dogwoods contain non-flavonoid glucoside salidroside derived from shikimic acid, iridoid glucosides were found to be unique in all red-fruited dogwoods, and they are derived from mevalonic acid (Bate-Smith et al., [@B10]; Jensen et al., [@B78]). The dogwoods iridoids were classified into three groups, including cornin and its precursor dihydrocornin, monotropein and its precursor geniposide as well as secoiridoids, secologanin and morroniside (Bate-Smith et al., [@B10]). Thus, the presence of iridoids (Figures [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}) in red-fruited dogwoods is considered a symplesiomorphy (Xiang et al., [@B179]), and confirms the close taxonomical relationship of *C. mas* and *C. officinalis*. The representative compounds of this group, such as loganin, loganic acid, cornin, sweroside, and cornuside, have been found in both species.

![The chemical structures of iridoids identified in fruits of *C. mas* and/or *C. officinalis*.](fphar-09-00894-g0001){#F1}

![The chemical structures of iridoids identified in fruits of *C. officinalis*.](fphar-09-00894-g0002){#F2}

Furthermore, the polyphenolic compounds are represented by anthocyanins, flavonoids and phenolic acids in fruits of *C. mas* and *C. officinalis*. Pelargonidin 3-*O*-galactoside followed by cyanidin 3-*O*-galactoside and delphinidin 3-*O*-galactoside were the most abundant anthocyanins in fruits of both species. Among flavonoids, quercetin, and kaempferol glycosides were detected in both species. Taking into consideration that flavonoids are widely distributed in plants, their occurrence was considered the similar characteristic for both species. Nevertheless, some discrepancy in the flavonoid composition occurs. Even more flavonoids have been referred by Huang et al. ([@B71]) but full availability of the studies concerning their identification or isolation is rather limited.

Last but not least, the similar constituents of *C. mas* and *C. officinalis* are considered triterpenoids, in particular represented by ursolic acid detected in both species, and carbohydrates. It is worth to note that neither in fruits of *C. mas* nor in fruits of *C. officinalis* phenylpropanoid esters have been reported to date, even though they usually co-exist with iridoids as it is observed in some plants from Oleaceae, Scrophulariaceae, Verbenaceae, Plantaginaceae, and Lamiaceae. This might be justified by the less significant role of shikimate pathway in biosynthesis of compounds in red-fruited dogwoods. Table [1](#T1){ref-type="table"} summarizes the key phytochemicals of fruits from *C. mas* and *C. officinalis* that can be found in the literature. The names of compounds have been provided as they were described in the referred literature. Due to the fact that HPLC-MS is currently one of the most popular method for elucidation of chemical composition of plant preparations, the molecular weights of phytochemicals were also listed (Table [1](#T1){ref-type="table"}) to help reader with comparing experimental data in order to preliminary identification detected constituents.

###### 

The comparison of phytochemical constituents from fruits of *C. mas* and *C. officinalis*.

  **Compound no**.         **Compound name**                                                         **Molecular weight**   ***C. mas***   ***C. officinalis***   **References**
  ------------------------ ------------------------------------------------------------------------- ---------------------- -------------- ---------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **IRIDOIDS**                                                                                                                                                    
  1                        Loganin                                                                   390                    X              X                      Du et al., [@B43]; Yokozawa et al., [@B196]; Cao et al., [@B20], [@B19]; Lin et al., [@B106]; Lee A. Y. et al., [@B100]; Lee N. H. et al., [@B102]; Xie et al., [@B185]; Cai et al., [@B18]; Deng et al., [@B35]; Ma et al., [@B114]; Perova et al., [@B135]; He et al., [@B66]; Jiang et al., [@B85]; Ye et al., [@B192]
  2                        8-Epiloganin                                                              390                                   X                      Ye et al., [@B192]
  3                        Loganic acid                                                              376                    X              X                      Yokozawa et al., [@B196]; Cao et al., [@B20], [@B19]; West et al., [@B176]; Deng et al., [@B35]; Ma et al., [@B114]; Sozanski et al., [@B157], [@B156]; Kucharska et al., [@B98]; Antolak et al., [@B4]; Ji et al., [@B81]
  4                        Cornin (verbenalin)                                                       388                    X              X                      Cao et al., [@B20]; Liu Z. et al., [@B110]; Cai et al., [@B18]; Perova et al., [@B135]; Jiang et al., [@B85]
  5                        Sweroside                                                                 358                    X              X                      Du et al., [@B43]; Cao et al., [@B20], [@B19]; Liu Z. et al., [@B110]; Cai et al., [@B18]; Deng et al., [@B35]; Perova et al., [@B135]; Jiang et al., [@B85]; Ye et al., [@B192]
  6                        Cornuside                                                                 542                    X              X                      Hatano et al., [@B63]; Du et al., [@B43]; Lin et al., [@B106]; Liu Z. et al., [@B110]; Lee A. Y. et al., [@B100]; Deng et al., [@B35]; Ma et al., [@B114]; Perova et al., [@B135]; Sozanski et al., [@B157]; Kucharska et al., [@B98]; Jiang et al., [@B85]; Antolak et al., [@B4]
  7                        Catalposide                                                               482                    X                                     Sochor et al., [@B154]
  8                        Morroniside                                                               406                                   X                      Du et al., [@B43]; Yokozawa et al., [@B196]; Cao et al., [@B20], [@B19]; Lin et al., [@B106]; Lee A. Y. et al., [@B100]; Lee N. H. et al., [@B102]; Cai et al., [@B18]; He et al., [@B66]; Jiang et al., [@B85]; Ji et al., [@B81]
  9                        7-α-*O*-Methylmorroniside                                                 420                                   X                      Ma et al., [@B114]; Jiang et al., [@B85]; Ye et al., [@B192]
  10                       7-β-*O*-Methylmorroniside                                                 420                                   X                      Xie et al., [@B185]; Ma et al., [@B114]; Jiang et al., [@B85]; Ye et al., [@B192]
  11                       7-α-*O*-Ethylmorroniside                                                  434                                   X                      Cao et al., [@B19]; Ma et al., [@B114]; Jiang et al., [@B85]; Ye et al., [@B192]
  12                       7-β-*O*-Ethylmorroniside                                                  434                                   X                      Cao et al., [@B19]; Ma et al., [@B114]; Jiang et al., [@B85]; Ye et al., [@B192]
  13                       7-*O*-Methylmorroniside                                                   420                                   X                      Liu Z. et al., [@B110]; Cai et al., [@B18]; Ji et al., [@B81]
  14                       7-*O*-Ethylmorroniside                                                    434                                   X                      Cao et al., [@B20]; Ji et al., [@B81]
  15                       7-β-*O*-Dimethyl butanedioate morroniside                                 550                                   X                      Park et al., [@B133]
  16                       (7*R*)-*n* butyl morroniside                                              462                                   X                      Lin et al., [@B106]
  17                       7-α-Morroniside                                                           406                                   X                      Xie et al., [@B185]; Ma et al., [@B114]; Ye et al., [@B192]
  18                       7-β-Morroniside                                                           406                                   X                      Xie et al., [@B185]; Ma et al., [@B114]; Ye et al., [@B192]
  19                       Logmalicid A                                                              506                                   X                      Ma et al., [@B114]
  20                       Logmalicid B                                                              506                                   X                      Ma et al., [@B114]
  21                       Cornusfuroside A                                                          542                                   X                      He et al., [@B65]
  22                       Cornusfuroside B                                                          542                                   X                      He et al., [@B65]
  23                       Cornusfuroside C                                                          542                                   X                      He et al., [@B65]
  24                       Cornusfuroside D                                                          622                                   X                      He et al., [@B65]
  25                       Swertiamarin                                                              374                                   X                      Cao et al., [@B20]; Liu Z. et al., [@B110]
  26                       Secoxyloganin                                                             404                                   X                      Ma et al., [@B114]
  27                       Secologanin (loniceroside)                                                388                                   X                      Jensen et al., [@B79]
  28                       Eriobioside                                                               568                                   X                      Liu Z. et al., [@B110]
  29                       7-Dehymorroniside                                                         404                                   X                      Cao et al., [@B19]
  30                       7-*O*-methyloganic acid                                                   390                                   X                      Cao et al., [@B19]
  31                       Cornuside A                                                               809                                   X                      Ye et al., [@B192]
  32                       Cornuside B                                                               809                                   X                      Ye et al., [@B192]
  33                       Cornuside C                                                               809                                   X                      Ye et al., [@B192]
  34                       Cornuside D                                                               809                                   X                      Ye et al., [@B192]
  35                       Cornuside E                                                               809                                   X                      Ye et al., [@B192]
  36                       Cornuside F                                                               809                                   X                      Ye et al., [@B192]
  37                       Cornuside G                                                               809                                   X                      Ye et al., [@B192]
  38                       Cornuside H                                                               809                                   X                      Ye et al., [@B192]
  39                       Cornuside I                                                               809                                   X                      Ye et al., [@B192]
  40                       Cornuside J                                                               809                                   X                      Ye et al., [@B192]
  41                       Cornuside K                                                               823                                   X                      Ye et al., [@B192]
  42                       Cornuside L                                                               779                                   X                      Ye et al., [@B192]
  43                       Cornuside M                                                               779                                   X                      Ye et al., [@B192]
  44                       Cornuside N                                                               779                                   X                      Ye et al., [@B192]
  45                       Cornuside O                                                               779                                   X                      Ye et al., [@B192]
  46                       Cornuside II                                                              779                                   X                      Liu Z. et al., [@B110]
  47                       Cornuside III                                                             506                                   X                      Wang et al., [@B174]
  48                       Cornuside IV                                                              506                                   X                      Wang et al., [@B174]
  49                       Corniside I                                                               779                                   X                      Cao et al., [@B19]
  50                       Corniside II                                                              542                                   X                      Cao et al., [@B20], [@B19]
  51                       Williamsoside D                                                           822                                   X                      Ye et al., [@B192]
  **ANTHOCYANINS**                                                                                                                                                
  52                       Pelargonidin                                                              271                    X                                     Sozanski et al., [@B156]
  53                       Pelargonidin 3-*O*-galactoside                                            433                    X              X                      Du and Francis, [@B42]; Seeram et al., [@B151]; Jayaprakasam et al., [@B76]; Vareed et al., [@B168]; Sozanski et al., [@B157], [@B156]; Kucharska et al., [@B98]
  54                       Pelargonidin 3-*O*-glucoside                                              433                    X                                     Jayaprakasam et al., [@B77]; Tural and Koca, [@B166]; Pawlowska et al., [@B134]; Capanoglu et al., [@B21]; Milenković-Andjelković et al., [@B116]; Antolak et al., [@B4]
  55                       Pelargonidin 3-*O*-robinobioside (pelargonidin 3-*O*-rhamnogalactoside)   579                    X                                     Du and Francis, [@B42]; Sozanski et al., [@B157], [@B156]; Kucharska et al., [@B98]; Antolak et al., [@B4]
  56                       Pelargonidin 3-*O*-rutinoside                                             579                    X                                     Pawlowska et al., [@B134]
  57                       Cyanidin                                                                  287                    X                                     Sozanski et al., [@B156]
  58                       Cyanidin 3-*O*-galactoside                                                449                    X              X                      Du and Francis, [@B42]; Seeram et al., [@B151]; Jayaprakasam et al., [@B77], [@B76]; Vareed et al., [@B168]; Pawlowska et al., [@B134]; Begic-Akagic et al., [@B11]; Drkenda et al., [@B41]; Sozanski et al., [@B157], [@B156]; Kucharska et al., [@B98]; Milenković-Andjelković et al., [@B116]
  59                       Cyanidin 3-*O*-glucoside                                                  449                    X                                     Tural and Koca, [@B166]; Capanoglu et al., [@B21]; Antolak et al., [@B4]
  60                       Cyanidin 3-*O*-robinobioside (cyanidin 3-*O*-rhamnogalactoside)           595                    X                                     Du and Francis, [@B42]; Sozanski et al., [@B157], [@B156]; Kucharska et al., [@B98]; Antolak et al., [@B4]
  61                       Cyanidin 3-*O*-rutinoside                                                 595                    X                                     Du and Francis, [@B42]; Tural and Koca, [@B166]; Capanoglu et al., [@B21]; Begic-Akagic et al., [@B11]; Drkenda et al., [@B41]
  62                       Peonidin 3-*O*-glucoside                                                  464                    X                                     Begic-Akagic et al., [@B11]; Drkenda et al., [@B41]
  63                       Delphinidin 3-*O*-glucoside                                               465                                   X                      Jayaprakasam et al., [@B77]
  64                       Delphinidin 3-*O*-galactoside                                             465                    X              X                      Du and Francis, [@B42]; Seeram et al., [@B151]; Jayaprakasam et al., [@B76]; Vareed et al., [@B168]; Sozanski et al., [@B157], [@B156]; Kucharska et al., [@B98]; Milenković-Andjelković et al., [@B116]
  65                       Petunidin 3-glucoside                                                     479                    X                                     Antolak et al., [@B4]
  **FLAVONOIDS**                                                                                                                                                  
  **Flavonols**                                                                                                                                                   
  66                       Quercetin                                                                 302                    X              X                      Kim and Kwak, [@B90]; Xie et al., [@B185]; Radovanović et al., [@B141]; Drkenda et al., [@B41]; Ma et al., [@B114]; Sochor et al., [@B154]; Antolak et al., [@B4]; Cosmulescu et al., [@B31]
  67                       Quercetin 3-*O*-β-D-xyloside (avicularin)                                 434                    X                                     Pawlowska et al., [@B134]; Begic-Akagic et al., [@B11]; Drkenda et al., [@B41]
  68                       Quercetin 3-*O*-α-L-rhamnoside (quercitrin)                               448                    X                                     Pawlowska et al., [@B134]; Begic-Akagic et al., [@B11]; Drkenda et al., [@B41]; Sochor et al., [@B154]; Popović et al., [@B137]; Bajić-Ljubičić et al., [@B9]
  69                       Quercetin 3-*O*-β-D-glucoside (isoquercetin, isoquercitrin)               464                    X              X                      Pawlowska et al., [@B134]; Liu Z. et al., [@B110]; Xie et al., [@B185]; Begic-Akagic et al., [@B11]; Drkenda et al., [@B41]; Ma et al., [@B114]; Milenković-Andjelković et al., [@B116]; Antolak et al., [@B4]; Popović et al., [@B137]; Bajić-Ljubičić et al., [@B9]
  70                       Quercetin 3-*O*-β-D-galactoside (hyperoside)                              464                    X              X                      Pawlowska et al., [@B134]; Xie et al., [@B185]; Begic-Akagic et al., [@B11]; Drkenda et al., [@B41]; Ma et al., [@B114]; Milenković-Andjelković et al., [@B116]; Popović et al., [@B137]; Bajić-Ljubičić et al., [@B9]
  71                       Quercetin 3-*O*-β-D-glucuronide (querciturone)                            478                    X              X                      Pawlowska et al., [@B134]; Lin et al., [@B106]; Liu Z. et al., [@B110]; Popović et al., [@B137]; Bajić-Ljubičić et al., [@B9]
  72                       Quercetin 3-*O*-rutinoside (rutin)                                        610                    X                                     Pawlowska et al., [@B134]; Begic-Akagic et al., [@B11]; Deng et al., [@B35]; Radovanović et al., [@B141]; Drkenda et al., [@B41]; Sochor et al., [@B154]; Milenković-Andjelković et al., [@B116]; Rudrapaul et al., [@B148]; Cosmulescu et al., [@B31]; Popović et al., [@B137]; Bajić-Ljubičić et al., [@B9]
  73                       Quercetin 3-*O*-robinobioside                                             610                    X                                     Begic-Akagic et al., [@B11]; Drkenda et al., [@B41]
  74                       Quercetin 3-*O*-β-D-glucuronide methyl ester                              492                                   X                      Ma et al., [@B114]
  75                       Quercetin 3-*O-β*-D-(6″-*n*-butyl glucuronide)                            534                                   X                      Lin et al., [@B106]
  76                       Kaempferol                                                                286                                   X                      Kim and Kwak, [@B90]; Xie et al., [@B185]
  77                       Kaempferol 3-*O*-β-D-galactoside (trifolin)                               448                    X              X                      Pawlowska et al., [@B134]; Ma et al., [@B114]
  78                       Kaempferol 3-glucoside                                                    448                    X                                     Begic-Akagic et al., [@B11]; Drkenda et al., [@B41]; Milenković-Andjelković et al., [@B116]
  79                       Kaempferol 3-*O*-β-D-rutinoside                                           594                                   X                      Ma et al., [@B114]
  80                       4′-Methylkaempferol (kaempferide)                                         300                                   X                      Xie et al., [@B185]
  81                       Myricetin                                                                 318                    X                                     Rudrapaul et al., [@B148]; Cosmulescu et al., [@B31]
  82                       Myricetin 3-galactoside                                                   480                    X                                     Antolak et al., [@B4]
  83                       2*R*, 3*R*-*trans*-Aromadendrin                                           288                    X                                     Rudrapaul et al., [@B148]
  84                       Aromadendrin 7-*O*-β-D-glucoside (sinensin)                               450                    X                                     Pawlowska et al., [@B134]
  85                       Naringenin 7-*O*-methylether                                              286                    X                                     Rudrapaul et al., [@B148]
  86                       7,3′-Dihydroxy-5,4′-dimethoxyflavanone                                    316                    X                                     Rudrapaul et al., [@B148]
  87                       4-Acetoxy-5,2′,4′,6′-β-pentahydroxy-3-methoxychalcone                     376                    X                                     Rudrapaul et al., [@B148]
  **Flavan-3-ols**                                                                                                                                                
  88                       (+) Catechin                                                              290                    X                                     Radovanović et al., [@B141]; Milenković-Andjelković et al., [@B116]
  89                       (-) Epicatechin                                                           290                    X                                     Radovanović et al., [@B141]; Milenković-Andjelković et al., [@B116]; Cosmulescu et al., [@B31]
  90                       (-) Epicatechin-3-*O*-gallate                                             442                                   X                      Lin et al., [@B106]
  91                       Procyanidin B1                                                            578                    X                                     Begic-Akagic et al., [@B11]; Drkenda et al., [@B41]
  92                       Procyanidin B2                                                            578                    X                                     Begic-Akagic et al., [@B11]; Radovanović et al., [@B141]; Drkenda et al., [@B41]; Milenković-Andjelković et al., [@B116]
  **PHENOLIC ACIDS**                                                                                                                                              
  93                       Gallic acid                                                               170                    X              X                      Tian et al., [@B164]; Du et al., [@B43]; Cao et al., [@B20]; Lin et al., [@B106]; Liu Z. et al., [@B110]; Cao et al., [@B19]; Youn and Jun, [@B200]; Cai et al., [@B18]; Deng et al., [@B35]; Radovanović et al., [@B141]; Sochor et al., [@B154]; Milenković-Andjelković et al., [@B116]; Rudrapaul et al., [@B148]; Jiang et al., [@B85]; Antolak et al., [@B4]; Cosmulescu et al., [@B31]
  94                       Caffeic acid                                                              180                    X              X                      Lin et al., [@B106]; Radovanović et al., [@B141]; Ma et al., [@B114]; Cosmulescu et al., [@B31]
  95                       *p*-Coumaric acid (coumaric acid)                                         164                    X              X                      Youn and Jun, [@B200]; Radovanović et al., [@B141]; Antolak et al., [@B4]; Cosmulescu et al., [@B31]
  96                       Ellagic acid                                                              302                    X              X                      Cao et al., [@B19]; Milenković-Andjelković et al., [@B116]; Cosmulescu et al., [@B31]
  97                       Protocatechuic acid                                                       154                    X              X                      Liu Z. et al., [@B110]; Antolak et al., [@B4]
  98                       Benzoic acid                                                              122                    X                                     Krivoruchko, [@B95]
  99                       Cinnamic acid (*trans*-cinnamic acid)                                     148                    X                                     Antolak et al., [@B4]; Cosmulescu et al., [@B31]
  100                      Ferulic acid                                                              194                    X                                     Krivoruchko, [@B95]; Antolak et al., [@B4]; Cosmulescu et al., [@B31]
  101                      Sinapic acid                                                              224                    X                                     Cosmulescu et al., [@B31]
  102                      Salicylic acid                                                            138                    X                                     Krivoruchko, [@B95]; Cosmulescu et al., [@B31]
  103                      Syringic acid                                                             198                    X                                     Radovanović et al., [@B141]; Cosmulescu et al., [@B31]
  104                      Vanillic acid                                                             168                    X                                     Krivoruchko, [@B95]; Cosmulescu et al., [@B31]
  105                      Rosmarinic acid                                                           360                    X                                     Antolak et al., [@B4]
  106                      Chlorogenic acid                                                          354                    X                                     Begic-Akagic et al., [@B11]; Deng et al., [@B35]; Drkenda et al., [@B41]; Sochor et al., [@B154]; Milenković-Andjelković et al., [@B116]; Cosmulescu et al., [@B31]
  107                      Neochlorogenic acid                                                       354                    X                                     Popović et al., [@B137]; Bajić-Ljubičić et al., [@B9]
  108                      Tachioside                                                                302                                   X                      Ma et al., [@B114]
  109                      3,5-Dihydroxy-2-(2-methoxy-2-oxoethyl) phenyl 4-hydroxybenzoate           318                                   X                      Ma et al., [@B114]
  110                      Caffeoyltartaric acid dimethyl ester                                      340                                   X                      Park et al., [@B133]
  111                      Caftaric acid monomethyl ester                                            326                                   X                      Lin et al., [@B106]
  **TRITERPENOIDS**                                                                                                                                               
  112                      Ursolic acid                                                              456                    X              X                      Jayaprakasam et al., [@B76]; Wang H. et al., [@B169]; Yu et al., [@B202]; Youn and Jun, [@B200]; He et al., [@B66]
  113                      Oleanolic acid                                                            456                                   X                      Wang H. et al., [@B169]; Lin et al., [@B106]
  114                      Arjunglucoside I                                                          666                                   X                      Liu Z. et al., [@B110]
  115                      Arjunglucoside II                                                         650                                   X                      Liu Z. et al., [@B110]
  **CARBOHYDRATES**                                                                                                                                               
  116                      Calcium pectate                                                           --                     X                                     Bilejić et al., [@B14]; Jaćimović et al., [@B74]
  117                      FCAP1                                                                     --                                    X                      Yang et al., [@B190]
  118                      PFCC-I                                                                    75,700                                X                      Li et al., [@B105]
  119                      PFCA-III                                                                  17,400                                X                      Li et al., [@B105]
  **TANNINS**                                                                                                                                                     
  120                      7-*O*-galloyl-D-sedoheptulose                                             362                                   X                      Yamabe et al., [@B188]; Yokozawa et al., [@B196]; Liu Z. et al., [@B110]; Park et al., [@B128]
  121                      2,3-Di-*O*-galloyl-β-D-glucose                                            484                                   X                      Okuda et al., [@B123]; Hatano et al., [@B62]; Cao et al., [@B20], [@B19]
  122                      1,7-Di-*O*-galloyl-D-glucose                                              484                                   X                      Liu Z. et al., [@B110]
  123                      1,2,3-Tri-*O*-galloyl-β-D-glucose                                         636                                   X                      Hatano et al., [@B62]; Cao et al., [@B20], [@B19]; Bhakta et al., [@B12]
  124                      1,2,6-Tri-*O*-galloyl-β-D-glucose                                         636                                   X                      Okuda et al., [@B123]; Hatano et al., [@B62]
  125                      1,2,3,6-Tetra-*O*-galloyl-β-D-glucose                                     788                                   X                      Okuda et al., [@B123]; Hatano et al., [@B62], [@B63]; Cao et al., [@B20], [@B19]; Bhakta et al., [@B12]
  126                      Tellimagrandin I                                                          786                                   X                      Okuda et al., [@B123]; Hatano et al., [@B62]; Cao et al., [@B19]; Bhakta et al., [@B12]
  127                      Tellimagrandin II (tellimagrandin-α, eugeniin)                            938                                   X                      Okuda et al., [@B123]; Hatano et al., [@B62], [@B63]; Cao et al., [@B20], [@B19]; Bhakta et al., [@B12]
  128                      Cornusiin A                                                               1,571                                 X                      Okuda et al., [@B123]; Hatano et al., [@B62]
  129                      Cornusiin B                                                               1,087                                 X                      Okuda et al., [@B123]; Hatano et al., [@B62]
  130                      Cornusiin C                                                               2,572                                 X                      Hatano et al., [@B62]
  131                      Cornusiin D                                                               1,722                                 X                      Hatano et al., [@B64]
  132                      Cornusiin E                                                               1,875                                 X                      Hatano et al., [@B64]
  133                      Cornusiin F                                                               2,202                                 X                      Hatano et al., [@B64]
  134                      Cornusiin G                                                               1,725                                 X                      Hatano et al., [@B63]
  135                      Camptothin A                                                              1,419                                 X                      Hatano et al., [@B64]
  136                      Camptothin B                                                              1,723                                 X                      Hatano et al., [@B64]
  137                      Gemin D (3-*O*-galloyl-4,6-(S)-hexahydroxydiphenoyl-D-glucose)            634                                   X                      Okuda et al., [@B123]; Hatano et al., [@B62]
  138                      Oenothein C                                                               784                                   X                      Okuda et al., [@B123]; Hatano et al., [@B62]
  139                      Isoterchebin                                                              955                                   X                      Okuda et al., [@B124], [@B123]; Hatano et al., [@B62]; Bhakta et al., [@B12]
  **CAROTENOIDS**                                                                                                                                                 
  140                      (13*Z*) + (13′*Z*)-Lutein                                                 568                    X                                     Horváth et al., [@B67]
  141                      (9*Z*) + (9′*Z*)-Lutein                                                   568                    X                                     Horváth et al., [@B67]
  142                      (9′*Z)*-Neoxanthin                                                        601                    X                                     Horváth et al., [@B67]
  143                      *(E)*-Neoxanthin                                                          601                    X                                     Horváth et al., [@B67]
  144                      Lutein-5,6-epoxide                                                        585                    X                                     Horváth et al., [@B67]
  145                      Luteoxanthin (epimers)                                                    601                    X                                     Horváth et al., [@B67]
  146                      Neochrome (epimers)                                                       553                    X                                     Horváth et al., [@B67]
  147                      β-carotene                                                                537                    X                                     Horváth et al., [@B67]
  148                      β-carotene-5,6-monoepoxide                                                553                    X                                     Horváth et al., [@B67]
  149                      β-cryptoxanthin                                                           553                    X                                     Horváth et al., [@B67]
  **FATTY ACIDS**                                                                                                                                                 
  150                      Behenic acid                                                              340                    X                                     Krivoruchko, [@B95]
  151                      Lauric acid                                                               200                    X                                     Brindza, [@B17]; Krivoruchko, [@B95]
  152                      Linoleic acid                                                             280                    X                                     Brindza, [@B17]; Krivoruchko, [@B95]
  153                      Linolenic acid                                                            278                    X                                     Brindza, [@B17]; Krivoruchko, [@B95]
  154                      Myristic acid                                                             228                    X                                     Brindza, [@B17]
  155                      Oleic acid                                                                282                    X                                     Brindza, [@B17]; Krivoruchko, [@B95]
  156                      Palmitic acid                                                             256                    X                                     Brindza, [@B17]; Krivoruchko, [@B95]
  157                      Plamitoleic acid                                                          254                    X                                     Brindza, [@B17]; Krivoruchko, [@B95]
  158                      Pentadecenic acid                                                         240                    X                                     Brindza, [@B17]
  159                      Pentadecanoic acid                                                        242                    X                                     Krivoruchko, [@B95]
  160                      Stearic acid                                                              284                    X                                     Brindza, [@B17]; Krivoruchko, [@B95]
  161                      Vaccenic acid                                                             282                    X                                     Brindza, [@B17]
  162                      *cis*-10,12-Octadecadienic acid                                           280                    X                                     Brindza, [@B17]
  **OTHER CONSTITUENTS**                                                                                                                                          
  163                      5-Hydroxymethylfurfural (5-Hydroxymethyl-2-furaldehyde)                   126                                   X                      Du et al., [@B43]; Yokozawa et al., [@B196]; Cao et al., [@B20], [@B19]; Cai et al., [@B18]; Jiang et al., [@B85]
  164                      Dimethyltetrahydrofuran *cis*-2,5-dicarboxylate                           188                                   X                      Kim and Kwak, [@B90]
  165                      β-sitosterol                                                              415                                   X                      Lin et al., [@B106]
  166                      Daucosterol-6′-malate                                                     692                                   X                      Xie et al., [@B185]
  167                      (1′*S*, 2′*R*)-guaiacyl glycerol 3′-O-β-D-glucoside                       376                                   X                      Ma et al., [@B114]
  168                      Mevaloside                                                                292                                   X                      Yokozawa et al., [@B196]
  169                      2,7-Anhydro-D-sedoheptulose (sedoheptulosan)                              192                                   X                      Liu Z. et al., [@B110]
  170                      Resveratrol                                                               228                    X                                     Sochor et al., [@B154]
  171                      Malic acid                                                                134                    X              X                      Cao et al., [@B19]; Begic-Akagic et al., [@B11]; Deng et al., [@B35]; Drkenda et al., [@B41]; Krivoruchko, [@B95]
  172                      Malic acid methyl ester                                                   148                                   X                      Cao et al., [@B20], [@B19]
  173                      Dimethyl malate                                                           162                                   X                      Miyazawa et al., [@B118]
  174                      Tartaric acid                                                             150                    X              X                      Cao et al., [@B19]; Begic-Akagic et al., [@B11]; Deng et al., [@B35]; Drkenda et al., [@B41]
  175                      Butoxysuccinic acid                                                       190                                   X                      Lin et al., [@B106]
  176                      Citric acid                                                               192                    X                                     Begic-Akagic et al., [@B11]; Deng et al., [@B35]; Drkenda et al., [@B41]
  177                      Succinic acid                                                             118                                   X                      Zhang Q. C. et al., [@B204]

Similarities of chemical composition
------------------------------------

### Iridoids

It is believed that particularly loganin (**1**) plays a crucial role in the formation sequences of highly oxidized glucosides of iridoids as well as in the biosynthesis of secoiridoids glucosides and indole alkaloids. The cyclization to a hemiacetal is likely to take place through the incorporation of an oxygen function into the C-8 position of secologanin (**27**) derived from loganin (**1**) to generate further iridoid derivatives (Inouye et al., [@B73]). Secoiridoids are believed to be even more advanced due to the more complicated biostynthetic steps (Xiang et al., [@B179]). Thus, the most closely related in the iridoids transformation pathway compounds, such as loganin (**1**), loganic acid (**3**), cornin (**4**), sweroside (**5**), and representative of secoiridoids, cornuside (**6**), have been detected both in fruits of *C. mas* and *C. officinalis* (Deng et al., [@B35]; Ma et al., [@B114]; Perova et al., [@B135]; Sochor et al., [@B154]; Kucharska et al., [@B98]; Jiang et al., [@B85]). However, it should be noted that in the 26 cultivars of *C. mas* it was shown that the most abundant iridoid was loganic acid (**3**) (81.5--461.1 mg/100 g fw) constituting 88--96% of total iridoids (86.9--493.7 mg/100 g fw). Cornuside (**6**) has already followed loganic acid (**3**) but its content was much lower than loganic acid (**3**) and maximally reached 36.2 mg/100 g fw (West et al., [@B175]; Kucharska et al., [@B98]). Only two reports describe the identification of loganin (**1**) and sweroside (**5**) in fruit of *C. mas* (Deng et al., [@B35]; Perova et al., [@B135]). Nevertheless, the reason of limited data on identification of loganin and sweroside in fruits of cornelian cherry is due to their low concentration compared to loganic acid. More detailed studies are needed in this field.

### Anthocyanins

The mature fruits from both *C. mas* and *C. officinalis* are dark red colored and for this reason they might be easily confused. Thus, in addition to iridoids (Figures [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}), anthocyanins (Figure [3](#F3){ref-type="fig"}), red colorant compounds, are widely distributed in fruits of these dogwoods. The content of anthocyanins increases when the fruits change their color from light yellow to dark red (Gunduz et al., [@B58]). Fruits of cornelian cherry and Asiatic dogwood contain in particular pelargonidin (**52**) and cyanidin (**57**) derivatives. Both in *C. mas* and *C. officinalis* pelargonidin 3-*O*-galactoside (**53**), cyanidin 3-*O*-galactoside (**58**), and delphinidin 3-*O*-galactoside (**64**) were detected and quantified. Pelargonidin 3-*O*-galactoside (**53**) (1.62 mg/g) and cyanidin 3-*O*-galactoside (**58**) (1.66 mg/g) have been noted as the most abundant anthocyanins of *C. mas* fresh fruit (Jayaprakasam et al., [@B76]; Vareed et al., [@B168]; Sozanski et al., [@B157]; Kucharska et al., [@B98]). The amount of pelargonidin 3-*O*-galactoside (**53**) in fruit of *C. officinalis* (0.78 mg/g) was approximately half of the concentration determined in fruit of *C. mas*. The other detected anthocyanins of *C. officinalis* fruit were present even at lower concentrations (0.15--0.21 mg/g; Vareed et al., [@B168]). In the literature, more attention has been focused on anthocyanins of *C. mas* (Pantelidis et al., [@B125]; Popović et al., [@B136]; Bilejić et al., [@B13]; Kucharska et al., [@B98]). These pigments were identified using methods such as HPLC, LC-ES/MS and NMR (Seeram et al., [@B151]; Kucharska et al., [@B98]), HPLC (Tural and Koca, [@B166]; Capanoglu et al., [@B21]) and LC-PDA-MS (Pawlowska et al., [@B134]). In some cultivars of the southeastern Europe peonidin 3-*O*-glucoside (**62**) followed by cyanidin 3-*O*-galactoside (**58**) was established as the major constituent of *C. mas* fruits (Drkenda et al., [@B41]).
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### Flavonoids

*Cornus* species have been proven to contain flavonols mostly quercetin (**66**) and kaempferol (**76**) derivatives (Figure [3](#F3){ref-type="fig"}). Most of reported compounds were identified as monoglycosides containing glucose, galactose, rhamnose, and glucuronic acid as a sugar moiety. The quercetin glycosides (**69--71**) as well as kaempferol 3-*O*-β-D-galactoside **(77)** were determined in both species (Pawlowska et al., [@B134]; Xie et al., [@B185]; Ma et al., [@B114]). The trace amounts of aglycone of flavonols such as quercetin (**66**) was found in fruits of both *C. mas* and *C. officinalis* (Xie et al., [@B185]; Rudrapaul et al., [@B148]).

### Phenolic acids

Three different groups of phenolic acids (Figure [3](#F3){ref-type="fig"}), including benzoic acid, *trans*-cinnamic acid and ellagic acid derivatives have been described in the fruits of *C. mas* and *C. officinalis*. The typical representatives of each group such as gallic acid (**93**), caffeic acid (**94**), *p*-coumaric acid (**95**), ellagic acid (**96**), and protocatechuic acid (**97**) have been found in both dogwoods (Liu Z. et al., [@B110]; Cao et al., [@B19]; Radovanović et al., [@B141]; Milenković-Andjelković et al., [@B116]; Rudrapaul et al., [@B148]; Antolak et al., [@B4]; Cosmulescu et al., [@B31]). Ellagic acid (**96**), which is a marker of ellagitannins occurrence, detected in the fruits of cornelian cherry suggests the presence of ellagitannins in this plant material. However, this hypothesis requires further investigation.

### Triterpenoids

Additionally, some other compounds such as triterpenoids (Figure [4](#F4){ref-type="fig"}) and carbohydrates have been identified in both species. Among terpenoids only ursolic acid (**112**) has been reported in the fruits of cornelian cherry and Asiatic dogwood (Jayaprakasam et al., [@B76]; Wang H. et al., [@B169]; Jang et al., [@B75]; He et al., [@B66]). This compound was often reported as an active constituent found in ethanolic and methanolic extracts from fruits of *C. officinalis* (Gao et al., [@B52]). In addition, other three triterpenoid acids (**113--115**), including oleanolic acid, have been identified in *C. officinalis* (Jayaprakasam et al., [@B76]; Wang H. et al., [@B169]; Jang et al., [@B75]; He et al., [@B66]).
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### Carbohydrates

Carbohydrates are the crucial compounds determining the quality of fruits due to the fact that the sugar content is a major parameter affecting a direct consumption of fruits in addition to food preservation aspects (Çopur et al., [@B30]; Brindza, [@B16]; Bilejić et al., [@B14], [@B13]). Thus, monosaccharides and polysaccharides are present in the fruits of both species. The fruits of *C. mas* contain the atypical fibers such as calcium pectate (**116**) (1.31%; Bilejić et al., [@B14]; Jaćimović et al., [@B74]). The crude fiber (0.36--0.76%) and total pectin (0.26--1.04%) contents were evaluated in *C. mas* fruits grown in different regions of Europe (Çopur et al., [@B30]; Sochor et al., [@B154]). Therefore, the juice of *C. mas* is considered an alternative fermentation substrate for the production of functional beverage. The simultaneous decreasing total sugars content and increasing contents of lactic and acetic acids were studied in the juice as well as unripe cornelian cherries fruits fermented by *Lactobacillus* sp. (Nouska et al., [@B122]; Czyzowska et al., [@B32]). It is worth to note that fermented cornelian cherry-derived products of iridoid glycosides and phenolic acids may complement gut microbiota and in this manner play a role of new probiotic functional products (Czyzowska et al., [@B32]). Additionally, the fibers and particularly oligosaccharides, which are generally found in fruits, are considered the non-digestible food ingredient stimulating the growth or selective activity of gut microbiota (Gibson, [@B55]). The dietary fiber in both cornelian cherries (Nawirska-Olszanska et al., [@B121]) and cornel dogwood fruits (Shao, [@B152]) is the important constituent of a diet determining human well-being due to a wide range of metabolic health benefits such as reduction of cholesterol level, blood pressure and body weight. Thus, the potential prebiotic activity of constituents such as dietary fiber from fruits of both dogwoods should not be excluded. On the other hand, a purification and isolation of bioactive polysaccharides of *C. officinalis* fruit (Yang et al., [@B190]; Li et al., [@B105]; You et al., [@B199]; Yin et al., [@B195]) have been also shown. The list of polysaccharides (**117--119**) identified in the fruits of *C. officinalis* is presented in Table [1](#T1){ref-type="table"}. The most abundant monosaccharide components of these polysaccharides were glucose, rhamnose and arabinose (Yang et al., [@B190]; Li et al., [@B105]). The monosaccharide profile of *C. mas* fruits have been represented by glucose, fructose and sucrose (Bilejić et al., [@B14]; Perova et al., [@B135]; Tarko et al., [@B163]; Antolak et al., [@B4]).

Differences in chemical composition
-----------------------------------

### General

Despite a wide range of similarities and close phylogenetic relationship of *C. mas* and *C. officinalis*, few differences in chemical composition of fruits can be found. The most valuable characteristic established only in fruits of *C. officinalis* seems to be the presence of tannins (**120--139**) as well as unique iridoids. Morroniside (**8**) is one of the most important iriodid glucoside reported in the fruits of *C. officinalis*. Additionally, 43 other iridoids (**9--51**) have been identified in this plant material. It should be underlined that co-existence of iridoids and tannins seems to be very rare in plants. Furthermore, 5-hydroxymethylfurfural (**163**) and steroids, such as β-sitosterol (**165**) and daucosterol-6′-malate (**166**) are unique for *C. officinalis*.

On the other hand, flavan-3-ols derivatives, such as procyanidin B1 (**91**) and B2 (**92**), carotenoids (**140--149**) and fatty acids (**150--162**) have been identified only in fruits of *C. mas*. It is worth to note that many reports provide data on ascorbic acid or pectin content in fruits of *C. mas* due to their dietary role. As far as the Asiatic dogwood is concerned, these data are completely missed.

The one comparative study on quantities of secondary metabolites in aqueous extracts from leaves of *C. mas* and *C. officinalis* have revealed that extracts of *C. mas* are characterized by lower content of flavonoids, hydroxycinnamic acids, total polyphenols and tannins than extracts of *C. officinalis* (Forman et al., [@B48]). On the other hand, no comparative quantitation of major secondary metabolites, except for anthocyanins (Seeram et al., [@B151]; Vareed et al., [@B168]) of dogwood fruits is available to date. Thus, further comparative elucidation of chemical composition as well as quantification of phytochemicals in fruits of both species still seem to be a challenge.

### Unique iridoids of *C. officinalis*

Although iridoids were classified as similar characteristic for both species, much more not widely known iridoids have been found only in fruits of *C. officinalis*. In particular, in contrary to the cornelian cherry fruits the major iridoid constituents of Asiatic dogwood fruits were isomers of α and β of morroniside (**8**) as well as their methyl and ethyl derivatives (**9--15**) (Du et al., [@B43]; West et al., [@B175],[@B176]; Xie et al., [@B185]; Jiang et al., [@B85]; Park et al., [@B133]; Ji et al., [@B81]). Additionally, apart from typical iridoids described previously, less-known compounds such as logmalicids A and B (**19--20**) as well as cornusfurosides A-D (**22--24**) were found in fruits of *C. officinalis* (Ma et al., [@B114]; He et al., [@B65]). Fifteen rare iridoid glucoside dimers, named cornusides A-O (**31--45**) (Figure [2](#F2){ref-type="fig"}), have been isolated from an aqueous extract of *C. officinalis* fruits (Ye et al., [@B192]).

### Tannins of *C. officinalis*

Similarly, tannins are attributed only to the fruits of *C. officinalis* and have been widely described. Therefore, tannins (Figures [5](#F5){ref-type="fig"}, [6](#F6){ref-type="fig"}) in the fruits of *C. officinalis* constitute the most important difference between both plant materials. Despite the mean content of tannins in fruits of *C. mas* was established as 0.34% (Gunduz et al., [@B58]), the detailed reports on the identification of tannins in the fruits of *C. mas* have been limited in contrary to *C. officinalis*. The Asiatic dogwood is particularly considered a rich source of hydrolyzable tannins (Okuda et al., [@B124], [@B123]). Twenty tannins (**120--139**), including ellagitannins and gallotannins, have been described in *C. officinalis*. The derivatives of galloylglucose (**121--125**), particularly digalloylglucose, have been identified to date. Tellimagrandin I (**126**) and II (**127**) as well as gemin D (**137**) and oenothein C (**138**) are representative of ellagitannins (Okuda et al., [@B124], [@B123]; Lee et al., [@B103]; Cao et al., [@B19]; Bhakta et al., [@B12]). Most of unique dimeric and trimeric hydrolyzable tannins named cornusiins A--G (**128--134**) have been found only in the fruits of *C. officinalis* to date (Okuda et al., [@B123]; Hatano et al., [@B62],[@B64], [@B63]). One of the bioactive constituents which should be mentioned due to the fact of potential biological activity is also 7-*O*-galloyl-D-sedoheptulose (**120**) (Yamabe et al., [@B188]; Yokozawa et al., [@B196]; Liu Z. et al., [@B110]; Park et al., [@B128]). It is worth to note that some tannins were detected in the fruits of cornelian cherry (Kucharska, [@B97]). However, their detailed identification was not conducted, and in fact the data concerning tannins in *C. mas* are not available.
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### Carotenoids and fatty acids of *C. mas*

Some lipophilic compounds such as carotenoids as well as fatty acids have been identified in the fruits of *C. mas* in contrast to *C. officinalis*. One report showed the determination of ten carotenoids (**140--149**) in the fruits of *C. mas* (Horváth et al., [@B67]), in addition to their quantitation in fresh and dried fruits (Rosu et al., [@B147]; Lofti et al., [@B111]). Carotenoids are believed to be regulators of lipid metabolism and antioxidants. Among carotenoids the most abundant in a diet is β-carotene (**147**), known singlet oxygen quencher and precursor for vitamin A (Grune et al., [@B56]). Despite limited data on this group of compounds in fruits of *C. mas*, their potential role in biological effectiveness of *C. mas* fruits should be considered. To the best of our knowledge there is no report on carotenoids in *C. officinalis*. Similarly, the available data on fatty acids in the fruits of Asiatic dogwood have been limited and the detailed analysis seems to be necessary. Fatty acids (**150--162**) such as linoleic acid (**152**), oleic acid (**155**) and palmitic acid (**156**) have been the most abundant in the fruits of *C. mas* (Krivoruchko, [@B95]).

### Diversity of phenolic compounds in *C. mas* and *C. officinalis*

Nine quercetin derivatives (**67--75**) have been identified in the fruits of *C. mas* (Pawlowska et al., [@B134]). Simultaneously, kaempferol 3-*O*-β-D-galactoside (**77**), myricetin (**81**), and naringenin 7-*O*-methylether (**85**) have been detected in the fruits of *C. mas* along with 7,3′-dihydroxy-5,4′-dimethoxyflavanone (**86**) (Pawlowska et al., [@B134]; Rudrapaul et al., [@B148]). It is worth to note that 2*R*, 3*S*-*trans*-aromadendrin (**83**) and its 7-*O*-β-D-glucoside (**84**), which are not so widely distributed in plants compared to quercetin and kaempferol glycosides, were determined in the fruits of *C. mas* (Pawlowska et al., [@B134]; Rudrapaul et al., [@B148]). On the other hand, some glycosides, such as quercetin 3-*O*-β-D-glucuronide methyl ester (**74**), quercetin 3-*O*-β-D-(6″-*n*-butyl glucuronide) (**75**), kaempferol 3-*O*-β-D-rutinoside (**79**) as well as kaempferide **(80)** have been reported in fruits of *C. officinalis* according to the available literature (Lin et al., [@B106]; Xie et al., [@B185]; Ma et al., [@B114]).

Flavan-3-ols such as catechin (**88**) and epicatechin (**89**) have been identified and quantified in the fruits of *C. mas* (Capanoglu et al., [@B21]; Milenković-Andjelković et al., [@B116]). In the study of Milenković-Andjelković et al. ([@B116]), catechin (**88**) was the predominant favan-3-ol in the fruit extracts of *C. mas* (Figure [3](#F3){ref-type="fig"}). Additionally, procyanidin B2 (**92**) was found only in the fruit extracts of *C. mas* (Radovanović et al., [@B141]; Milenković-Andjelković et al., [@B116]). The degree of polymerization in the fruits of cornelian cherry was assessed at the level of 63 total bound (epi)catechin units/end units (Capanoglu et al., [@B21]).

The mixture of benzoic acid (**98**) and cinnamic acid (**99**) derived phenolic acids, including ferulic acid (**100**), sinapic acid (**101**) as well as vanillic acid (**104**), was identified in the fruits of *C. mas* (Radovanović et al., [@B141]; Milenković-Andjelković et al., [@B116]; Rudrapaul et al., [@B148]; Cosmulescu et al., [@B31]). In addition, the esters formed between phenolic acids\' particles, such as rosmarinic acid (**105**) and chlorogenic acid (**106**) have been found only in the fruits of cornelian cherry (Figure [4](#F4){ref-type="fig"}; Deng et al., [@B35]; Antolak et al., [@B4]; Popović et al., [@B137]; Bajić-Ljubičić et al., [@B9]). The unique derivatives of phenolic acids such as tachioside (**108**), caffeoyltartaric acid dimethyl ester (**110**), and caftaric acid monomethyl ester (**111**) are characteristic for Asiatic dogwood\'s fruits (Figure [4](#F4){ref-type="fig"}; Lin et al., [@B106]; Ma et al., [@B114]; Park et al., [@B133]).

### Other constituents

Due to the fact of the usage of *C. mas* for a production of concentrates, jams, and even more often fruit juice and alcoholic beverages, rheological and physicochemical properties related to the quality of liquid foods have been reported (Güleryüz et al., [@B57]; Brindza, [@B17]; Kalyoncu et al., [@B86]; Karadeniz et al., [@B89]; Yilmaz et al., [@B193]; Hassanpour et al., [@B61]; Gastoł et al., [@B54]; Bilejić et al., [@B13]; Rad et al., [@B140]; Bozdogan, [@B15]). In particular, apart from titrable acidity, soluble solid content as well as total sugars and pectin content, vitamin C was often quantified in the fruits of *C. mas*. They were characterized by the high content of ascorbic acid ranging from 43.6 to 76.7 mg/100 g, or even reaching 112 mg/100 g in Turkish cultivars (Güleryüz et al., [@B57]; Çopur et al., [@B30]; Demir and Kalyoncu, [@B34]; Brindza, [@B16], [@B17]; Yalcinkaya et al., [@B187]; Yilmaz et al., [@B193]; Rop et al., [@B146]; Dokoupil and Rezníček, [@B38]; Hassanpour et al., [@B61]; Bilejić et al., [@B13]; Kostecka et al., [@B94]). However, it was noted that cornelian cherry fruits from Greece were characterized by higher content of vitamin C than these ones from Poland (Kostecka et al., [@B94]). On the other hand, some physicochemical properties of cornel dogwood wine during its fermentation and storage were studied once (Zhang Q. -A. et al., [@B203]).

Few reports considered the potential bioactivity of 5-hydroxymethylfurfural (**163**) isolated from fruits of *C. officinalis* (Figure [7](#F7){ref-type="fig"}; Du et al., [@B43]; Cao et al., [@B20], [@B19]; Jiang et al., [@B85]). Additionally, steroid compounds including β-sitosterol (**165**) and daucosterol-6′-malate (**166**) have been identified only in fruits of *C. officinalis* (Figure [7](#F7){ref-type="fig"}; Lee et al., [@B103]; Lin et al., [@B106]; Xie et al., [@B185]).

![The chemical structures of other compounds identified in fruits of *C. mas* and/or *C. officinalis*.](fphar-09-00894-g0007){#F7}

Similarities and differences of pharmacological effects or biological activities {#s3}
================================================================================

General
-------

Taking into account different medical approaches in the traditional medicine in ancient Europe and Asia, in particular China, it is rather interesting that there are some similar indications reported for both species. They have been traditionally used to improve liver and kidney functions and are considered therapeutically usefull due to their antidiabetic and antimicrobial properties. Considering the phytochemical similarities between both species the comparable use of both species is scientifically reasonable. For this reason, the antidiabetic effect as well as renal and hepatic protective activities of both species were particularly considered in the reported studies. In addition, the positive effects on central nervous and cardiovascular systems of both species have been noted. The background of these effects seems to be the antioxidant activity as well as an amelioration of inflammatory processes through regulation of NF-κB and MAPK signaling pathways by constituents of extracts from fruits of both species. The isolated constituents of fruits, such as cornuside (**6**), loganin (**1**), ursolic acid (**112**), anthocyanins, and more specific for *C. officinalis* morroniside (**8**), and 7-*O*-galloyl-D-seduheptulose (**120**), demonstrated the biological impact. However, the pharmacological effect of other phytochemicals found in fruits of both species should not be excluded in the provided reports. Thus, the accurate qualitative and quantitative characterization of phytochemicals in extracts is required in the studies, and the beneficial role of complex phytochemical formulation providing the synergistic or additive effect should be underlined.

The antimicrobial and antitumor activities of both species seem to be mostly related to the presence of polyphenolic compounds in fruit extracts. However, these activities of both species do not seem to be well-established.

Table [2](#T2){ref-type="table"} demonstrates similarities and differences of the biological or pharmacological activities between the preparations from fruits of both species. The biologically or pharmacologically active groups of compounds or isolated constituents of fruit extracts were included in Table [2](#T2){ref-type="table"}.

###### 

Similarities and differences of the biological or pharmacological activities of fruits from *C. mas* and *C. officinalis*.

  **Biological and pharmacological activities**   **Preparations or characterized natural products responsible for the activity of the fruits**   
  ----------------------------------------------- ----------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------
  Antidiabetic activity                           Hydroalcoholic extracts Dried fruits (powder) Anthocyanins Ursolic acid                         Hydromethanolic extract Ethanolic extract Aqueous extracts Dried fruit powder 7-*O*-galloyl-D-sedoheptulose Loganin Morroniside Ursolic Acid Oleanolic acid
  Antihyperlipidemic activity                     Dried fruits (powder) Anthocyanins Loganic acid Ursolic acid                                    Not reported
  Anti-inflammatory activity                      Dried powder Polyphenols-rich extract Loganic acid                                              Aqueous extract Cornuside
  Neuroprotective Anti-amnesic activity           Dried fruits (powder)                                                                           Methanolic extract Iridoid glycosides *p*-Coumaric acid Ursolic acid Gallic acid
  Hepatoprotective activity                       Hydromethanolic extract                                                                         Aqueous extract
  Antioxidant activity                            Dried fruits (powder) Ethanolic extract                                                         Ethanolic extract Aqueous extract Iridoid glycosides Polysaccharides
  Anticoagulant activity                          Dried fruits (powder) Hydromethanolic extract                                                   Not reported
  Cardioprotective activity                       Hydromethanolic extract Aqueous extract                                                         Aqueous extract Cornuside
  Kidneyprotective activity                       Hydromethanolic extract                                                                         Total triterpene acids
  Antitumor activity                              Hydromethanolic extract Ethanolic extract Aqueous extract                                       Hydromethanolic extract Ethanolic extract Aqueous extract
  Antimicrobial activity                          Hydromethanolic extract Ethanolic extract Aqueous extract Dried fruit powder                    Aqueous extract
  Insecticidal activity                           Not reported                                                                                    Methanolic extract
  Antiosteoporotic activity                       Not reported                                                                                    Aqueous extract
  Immunomodulatory activity                       Not reported                                                                                    Aqueous extract
  Ophtalmic activity                              Anthocyanin-iridoid fraction Loganic acid                                                       Not reported

*Modified according to Dinda et al. ([@B37]) and Hosseinpour-Jaghdani et al. ([@B69])*.

*Modified according to Huang et al. ([@B71])*.

Similar biological or pharmacological activities of *C. mas* and *C. officinalis*
---------------------------------------------------------------------------------

### Antidiabetic effect

Comparing the reported traditional therapeutic use of fruits from *C. mas* and *C. officinalis* it is obvious that the treatment of metabolic disorders played an important role. Based on different fundamentals of ancient medicine in China and Europe or western Asia and despite missing modern diagnostic tools for precise detection of diabetes, the physicians recognized definitely metabolic disease in the distant past and tried to treat their accompanying symptoms. Under this point of view the use of fruits from both species should be discussed in order to their potential usefulness in the treatment of metabolic diseases in different geographic regions. Due to the wide spectrum of natural compounds and modern investigations of their biological activity an antidiabetic effect of cornelian cherry seems to be proven. Based on some animal experiments investigating the effect of preparations made from *C. mas* fruits the blood glucose decreasing activity and enhancement of insulin sensitivity were demonstrated (Jayaprakasam et al., [@B76]; Mirbadalzadeh and Shirdel, [@B117]; Narimani-Rad et al., [@B120]; Asgary et al., [@B8]). The same findings were reported also for fruits of *C. officinalis* (Park et al., [@B129]; Gao et al., [@B53]; Liu et al., [@B107]; Han et al., [@B60]). Data from clinical studies evaluating the therapeutic effect of the herbal preparation are available only for *C. mas*. One study on the fruit extract showed its antidiabetic effect associated with the reduction of risk factors for secondary diseases (Soltani et al., [@B155]). Comparing the chemical constituents present in both species and their biochemical or pharmacological effects some similarities can be seen. In the extract of both species polyphenolic compounds (e.g., flavonoids, anthocyanins), which inhibit α-glucosidase activity combined with decreasing postprandial blood glucose level, are present (Park et al., [@B129]; Asgary et al., [@B8]; Shishehbor et al., [@B153]). Ursolic acid (**112**) also present in both species is capable to stimulate the glucose uptake through the phosphorylation of insulin receptor (Zhang et al., [@B205]). Specific antidiabetic effects were reported for 7-*O*-galloyl-D-seduheptulose (**120**) and iridoids \[e.g., loganin (**1**), morroniside (**8**)\] present in *C. officinalis* (Yamabe et al., [@B188]; Park et al., [@B130], [@B126]; He et al., [@B66]) as well as for cyanidin 3-*O*-galactoside (**58**) and cyanidin 3-*O*-glucoside (**59**) present in *C. mas* (Jayaprakasam et al., [@B77]). On the other hand, loganin (**1**) and ursolic acid (**112**) were not able to affect an expression of phosphoenolpyruvate carboxykinase (PEPCK) in rat hepatoma H4IIE cell line on the contrary methanolic extract of *C. officinalis* fruit (50 μg/ml) which exerted insulin mimetic effect in this manner, and one of its fraction enhanced insulin secretion by rat insulin-secreting BRIN-BD11 cells in response to high glucose concentration (16.7 mM; Chen et al., [@B24]). Although there is only one published clinical study of the fruit extract from *C. mas* the antidiabetic effect seems to be proven (Soltani et al., [@B155]).

The prolonged high blood glucose concentration leads to progressive lesions in heart, kidney, blood vessels and other organs. Moreover, increased intracellular reducing sugars and their derivatives may participate in glycation and formation of advanced glycation endproducts (AGEs) which play an important role in further development of chronic diabetic complications, atherosclerosis and aging process. The phytochemicals of *C. officinalis* fruits such as gallotannins, particularly 7-*O*-galloyl-D-sedopheptulose (**120**), and morroniside (**8**) inhibited AGE formation or inhibited expression of receptors for AGEs (Yamabe et al., [@B188]; Lee et al., [@B101]; Park et al., [@B132], [@B128]; Lv et al., [@B112]). Due to the series of diabetes type II complications, the inhibition of AGE formation seems to be a promising target for therapeutic intervention supporting the AGE-related disorders.

### Antioxidant activity

In addition to the studies of total phenolic, flavonoid, and anthocyanins content, antioxidant properties of the extracts from cornelian cherries were determined in a correlation with these phytochemicals. Apart from polyphenols, ascorbic acid and carotenoids in *C. mas* play a significant antioxidant role. Thus, both antioxidants content and antioxidant capacity of dogwoods fruits are factors determining the quality of cultivars and basic physicochemical properties. *In vitro* assays such as free radical scavenging with DPPH (2,2-diphenyl-1-picrylhydrazyl radical), ferric ion reducing antioxidant power (FRAP), total antioxidant capacity with ABTS^+^ (2,2-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) radical cation) and oxygen radical absorbance capacity (ORAC) were the most frequently used methods in a wide range of studies on *C. mas* (Dragović-Uzelac et al., [@B40]; Pantelidis et al., [@B125]; Hamid et al., [@B59]; Celep et al., [@B22]; Popović et al., [@B136]; Gunduz et al., [@B58]; Pyrkosz-Biardzka et al., [@B138]; Stankovic et al., [@B158]; Milenković-Andjelković et al., [@B116]; Hosu et al., [@B70]; Moldovan et al., [@B119]) and *C. officinalis* (Lee et al., [@B104]; West et al., [@B175]; Hwang et al., [@B72]). Moreover, the hydromethanolic extracts of some cornelian cherry fruit cultivars from Turkey demonstrated significant H~2~O~2~ scavenging activity (79.1%; Ersoy et al., [@B44]). Galactosides of cyanidin (**58**) and pelargonidin (**53**) detected in both species inhibited lipid peroxidation by 70.2 and 40.3% in an iron-catalyzed liposomal model, respectively (Seeram et al., [@B151]). On the other hand, the antioxidant properties, including protection of catalase and glutathione peroxidase, of *C. officinalis* fruits are also assigned to polysaccharides (Li et al., [@B105]; Wu et al., [@B177]) and ursolic acid (Yu et al., [@B202]).

### Anti-inflammatory activity

Anti-inflammatory and analgesic activities of extracts are reported for both species. As mentioned before most of the results were obtained in cell culture or biochemical experiments. The beneficial effect of aqueous extract from fruits of *C. officinalis* and its iridoid constituent cornuside (**6**) on protein expression of COX-1 and COX-2 as well as PGE~2~ production in LPS-induced macrophages RAW 264.7 was shown (Sung et al., [@B161]; Choi et al., [@B27]). Similarly, ursolic acid (**112**), which was isolated from an ethanolic extract of *C. officinalis* inhibited NF-κB activation in LPS-stimulated peritoneal macrophages. Oral administration of ursolic acid (**112**) significantly inhibited 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colon shortening and MPO activity in mice, and also suppressed TNBS-induced COX-2 and iNOS expression as well as NF-κB activation in colon tissues. Ursolic acid (**112**) may ameliorate colitis by regulating NF-κB and MAPK signaling pathways via the inhibition of LPS binding to toll-like receptors 4 (TLR4) on immune cells (Jang et al., [@B75]). Taking into consideration a wide range of ingredients and general mechanisms responsible for induction or prevention of inflammation, *in vitro* results fit to conclusions obtained from animal experiments and a clinical study (Sung et al., [@B161]; Sozanski et al., [@B157], [@B156]; Moldovan et al., [@B119]). In particular, cornuside (**6**) was indicated as an immunomodulatory dogwood-derived compound in a model of sepsis in rats (Jiang et al., [@B82]). The link between chronic inflammation and cancer involves cytokines and mediators of inflammatory pathways. Plants contain numerous secondary metabolites shown to modulate inflammatory pathways. Studies have shown that these metabolites, among which some are used in traditional medicine, can reduce inflammation and carcinogenesis (Desai et al., [@B36]). Phenolic and other compounds present in the extracts of the dogwood fruits target various inflammation-related molecules and pathways associated with cancer (Choi et al., [@B27]). Polyphenols modulate important cellular signaling processes such as NF-κB (nuclear factor κ light-chain enhancer of activated B cells) activation, chromatin structure, glutathione biosynthesis, Nrf2 (nuclear redox factor) activation, direct ROS scavenging or antioxidant effect via glutathione peroxidase activity. Finally, they regulate inflammatory genes in macrophages and lung epithelial cells. Thus, recent data suggest that polyphenols can play a role of modifiers of signal transduction pathways to elicit their beneficial effects. However, to correlate this with beneficial effects in humans their metabolism and bioavailability need to be considered (Rahman et al., [@B144]).

### Renal and hepatic protective activities

The metabolism of xenobiotics is often linked with the production of harmful radicals or metabolites damaging such organs like liver and kidney resulting in inflammation or carcinogenic transformation. As mentioned before natural products present in fruits of both species are able to inhibit both damage generated by radicals and inflammatory processes *in vitro*. Animal experiments performed with methanolic extracts of *C. mas* fruits are reported to show hepatoprotective activities against chemically induced hepatotoxicity after oral application. The dosage used in the investigations with rats ranging from 200 to 700 mg/kg body weight (Abbasi et al., [@B1]; Alavian et al., [@B3]; Saei et al., [@B149]). Similar reports concerning *C officinalis* are also published (Lee N. H. et al., [@B102]). The protective effect on kidneys is described for both species using comparable animal experimental settings (Yokozawa et al., [@B198]; Jiang et al., [@B84]; Abbasi et al., [@B1]; Es Haghi et al., [@B45]). In particular, the iridoids \[loganin (**1**) and morroniside (**8**)\] present mainly in the fruits of *C. officinalis* as well as 7-*O*-galloyl-D-sedoheptulose (**120**) are able to prevent renal damage in diabetic rats (Xu et al., [@B186]; Park et al., [@B131]).

### Antimicrobial effect

Antibacterial effects are also reported for extracts of the fruits from both species without remarkable activity (Mau et al., [@B115]; Krzyściak et al., [@B96]; Turker et al., [@B167]; Radovanović et al., [@B141]; Kyriakopoulos and Dinda, [@B99]; Milenković-Andjelković et al., [@B116]; Hosseinpour-Jaghdani et al., [@B69]). Due to the presence of a complex of different phenolic compounds in dogwood fruits the antimicrobial activity is not surprising. All phenolic compounds to a certain extent express this activity (Radulović et al., [@B142]). In addition, it is worth to note that some phytochemicals of plant materials may reduce the adhesion of bacteria (*Asaia* spp.) found in food products/beverages, as it was shown in the case of juices of cornelian cherry (Antolak et al., [@B4]). Thanks to this, the antiadhesive activity of fruit-derived constituents prevents the formation of biofilm on the solid surface, which can be potential source of product contamination. Thus, they are likely to protect both food and plant preparations used in the phytotherapy against loss of organoleptic quality manifested by turbidity and flock formation.

### Effects on memory and brain functions

The phytotherapy of diseases or complaints related to the central nervous systems, including memory retention, has a long tradition in Asian and also in European medicine. The reported anti-amnestic and neuroprotective activities of both species seem to be based on similar constituents such as flavonoids and terpenoids which express antioxidant or more precisely radical scavenging effects (Dinda et al., [@B37]; Cooper and Ma, [@B29]; Huang et al., [@B71]). Animal experiments as well as biochemical investigations showed that the dried fruit powder and fruit extracts were able to increase level of physiological antioxidants such as glutathione and antioxidative enzymes, including superoxide dismutase or catalase, as well as to prevent cells and tissues against free radicals in this manner (Lee et al., [@B104]; Kim et al., [@B91]; Celep et al., [@B22]; Lee N. H. et al., [@B102]; Sozanski et al., [@B157]). In particular, morroniside (**8**) has been proved to protect human neuroblastoma cells against H~2~O~2~-induced stress, inhibit the apoptosis and accumulation of intracellular Ca^2+^ as well as restore the mitochondrial potential in SH-SY5Y cell line (Wang W. et al., [@B170]; Wang et al., [@B171]). The results of *in vitro* studies in cellular models were confirmed in cerebral ischemia model in rats. Morroniside (**8**) at the concentration range from 30 to 270 mg/kg body weight significantly reduced infarct volume, alleviated neurological impairment caused by ischemia/reperfusion-induced brain injury as well as enhanced progenitor cell proliferation (Wang et al., [@B172]; Sun et al., [@B159],[@B160]). Some special reports indicate the improvement of neurological functions in rats after feeding with iridoid glycosides from *C. officinalis* (Yao et al., [@B191]). Additionally, in the experimental autoimmune encephalomyelitis in animal models the administration of cornel iridoid glycoside significantly attenuated the symptoms of multiple sclerosis via an increased expression of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) as well as inhibition of JAK/STAT1 and JAK/STAT3 phosphorylation and reduction of proinflammatory mediators, such as TNF-α, IL-1β, IFN-γ, IL-17 (Yin et al., [@B194]; Qu et al., [@B139]). Iridoids of *C. officinalis* also protect glutamate-injured hippocampal cells (Jeong et al., [@B80]). A treatment of rats with a polyphenolic-rich dried fruits of *C. mas* resulted in increased activity of catalase in brain tissue, while in plasma it caused the opposite effect. On the other hand, the increased activity of paraoxonase-1 (PON1) was observed both in rats brain and plasma what potentiate a protective effect of PON1 with regard to the LDL and prevention of oxidative stress. Polyphenols and ascorbic acid of *C. mas* fruits were linked with this effect. Therefore, both neuroprotective and cardioprotective effects were assumed (Francik et al., [@B50]).

On the other hand, cornuside (**6**) as a representative for secoiridoid glycosides turned out to be an inhibitor of β-site amyloid precursor protein cleaving enzyme 1 (BACE1; IC~50~ = 55.8 μg/ml) but was a weak inhibitor of acetylocholinesterase (IC~50~ \> 100 μg/ml) and butyrylocholinesterase (IC~50~ \> 500 μg/ml). Other polyphenolic compounds isolated from fruits of *C. officinalis* such as tellimagrandin I (**126**), tellimagrandin II (**127**) and isoterchebin (**139**) were significant inhibitors of all enzymes engaged in the progression of neurodegeneration in Alzheimer\'s disease (Bhakta et al., [@B12]). Morroniside (**8**) was found to inhibit tau hyperphosphorylation, another Alzheimer\'s disease marker, via protein phosphatase 2A activation in human neuroblastoma SK-N-SH cells (Yang et al., [@B189]). The downregulation of mRNA expression of STIM1 and the inhibition of extracellular Ca^2+^ influx in PC12 cell line by an aqueous extract from fruits of *C. officinalis* were proposed as the potential inducing mechanisms of neurite generation and differentiation (Wang et al., [@B173]).

### Cardioprotective activity

In close relation to neuroprotection linked with antioxidant properties, antihyperlipidemic and cardioprotective activity of both herbal preparations were demonstrated by *in vitro* as well as *in vivo* experiments. As mentioned before these protective effects seem to be based on the same chemical constituents. In animal studies for both plant materials evidence was shown for antihypertensive effects, decreasing blood pressure and reduction of circulating cholesterol concentration (Park et al., [@B127]; Rafieian-Kopaei et al., [@B143]; Asgary et al., [@B8]; Sozanski et al., [@B157], [@B156]; Hosseinpour et al., [@B68]). The ethanolic extract of *C. officinalis* fruits has significantly inhibited adipogenesis (87.1%) in 3T3-L1 preadipocytes (Roh and Jung, [@B145]; Kang et al., [@B87]). In addition, it is believed that the metabolic diseases potentially correlate with endocrine hormones due to considerable role of cortisol in cholesterol metabolism (Fraser et al., [@B51]). One report demonstrated reduction of cortisol concentration in plasma of hamsters after supplementation of *C. mas* fruits (Lofti et al., [@B111]). In relation to lipid metabolism, the ability of morroniside (**8**) and 7-*O*-galloyl-D-sedoheptulose (**120**) to decrease the expression of proteins associated with lipid homeostasis SREBP-1 and SREBP-2 (sterol regulatory element binding proteins) in kidneys of mice (*db/db*) and rats has been shown (Yokozawa et al., [@B197]; Park et al., [@B130]). The direct cardioprotective role of cornuside present in both species has been established. The decrease of infarct volume after myocardial ischemia/reperfusion injury in rats treated with cornuside (**6**) has been assigned to the reduction of polymorphonuclear leukocytes infiltration, myeloperoxidase (MPO) activity and malondialdehyde (MDA) production in myocardial tissue as well as lower serum-levels of pro-inflammatory mediators (Jiang et al., [@B83]). Furthermore, this compound dilated vascular smooth muscles through endothelium-dependent NO/cGMP signaling pathway (Kang et al., [@B88]). Unfortunately, no convincing human studies addressing these biological activities have been published so far. Although there is one published clinical study of a fruit extract from *C. mas* demonstrating its antidiabetic effect associated with the decreasing risk factors of cardiovascular diseases (Soltani et al., [@B155]). These results revealed a trend in another clinical trial toward amelioration of lipid profile and vascular inflammation following addition of *C. mas* extracts to the daily diet of dyslipidemic children and adolescents but these findings need to be verified by larger scale trials (Asgary et al., [@B6]). However, human studies with extracts of *C. officinalis* fruits have not been published so far. Discussing these effects with respect to the ethnopharmacological reports regarding the traditional use of both species in the past some evidence for beneficial effects on heart and circulation system may exist. This concerns especially the traditional use of *C. mas* to treat disorders or complaints related to aging processes like diabetes, ischemia or cardiovascular diseases (Dinda et al., [@B37]; Hosseinpour-Jaghdani et al., [@B69]). Due to the use of *C. officinalis* in TCM as a component of complex drug mixtures (Chen et al., [@B24]; Liu et al., [@B108]; Dai et al., [@B33]), a clear assignment to effects on heart and circulation system is rather difficult. However, in preparations of TCM used for treatment of diseases often related to aging processes the fruits of *C. officinalis* are abundant constituents (Chinese Pharmacopoeia, [@B26]).

### Antitumor activity

Despite the reports of antitumor activity of *C. mas* and *C. officinalis* fruits, the data do not provide any evidence that the fruits of both species show any real antitumor activity. All results from the literature refer to cytotoxic activities in different tumor cell lines (A549, MCF-7, SKOV3, PC-3, HepG2, U937) but not to animal experiments or human studies (Chang et al., [@B23]; Yousefi et al., [@B201]). Even though a cytotoxic effect on tumor cells is observed, the antitumor activity is not fully addressed and cannot be interpreted. This kind of over-interpretation of *in vitro* studies occurs very often but has no pharmacological relevance. All polyphenolic compounds, including the most abundant constituents of dogwood fruit extracts, bind to cells in culture leading to the induction of the biological effect. Consequently, the cytotoxicity or inhibition of proliferation associated with changes in signaling pathways occur. Only a clear selectivity in cytotoxicity between tumor and non-tumor cells corresponding with appropriate animal *in vivo* experiments opens up the possibility for the statement of antitumor activity. The reported antioxidant activity for both species (Dinda et al., [@B37]; Hosseinpour-Jaghdani et al., [@B69]; Huang et al., [@B71]) might be a hint for protective effects against tumor-inducing free radicals but for both species only *in vitro* models have been used to demonstrate such effects (Chang et al., [@B23]; Chu et al., [@B28]; Turker et al., [@B167]; Yousefi et al., [@B201]). In particular, the flavonoids are regarded as safe and easily obtainable. For this reason, they are considered ideal candidates for cancer chemoprevention or associated agents in clinical treatment (Sak, [@B150]).

Unique biological and pharmacological activities of *C. mas* and *C. officinalis* {#s4}
=================================================================================

General
-------

The unique anticoagulant and ophthalmic effects of dried fruits and extracts or anthocyanin-iridoid fractions from fruits of *C. mas* were assessed in the available reports. On the other hand, the antiosteoporotic, immunomodulatory and insecticidal properties of *C. officinalis* fruits, their extracts or constituents, such as morroniside (**8**), polysaccharides or 5-hydroxymethylfurfural (**163**), and dimethyl malate (**173**) were only found. Moreover, there is no available report on the antihyperlipidemic activity of *C. officinalis*. The circumstances of needs in the traditional eastern or western medicine requiring scientific confirmation are a pivotal factor determining scientific research. For this reason, these differences between *C. mas* and *C. officinalis* might arise from the lack of dedicated studies or even from different cultural needs resulting from the geographical distribution of both species.

*Cornus mas* L.
---------------

### Anticoagulant effect

Historical reports about an anticoagulant effect of fruits from *C. mas* do not exist. According to the interpretation of diseases of the circulation system, their etiology was rather assumed in disturbances of the digestion tract based on the theory of the four humors. The knowledge of functions and pathological significance of platelets or the blood coagulation system is the result of research in the twentieth century. For this reason, single reports about pharmacological effects of traditionally used herbal remedies on blood coagulation or platelet function are rather remarkable. Thus, it is worth to note that the dried fruit powder and hydromethanolic extracts of the fruits of *C. mas* showed an anticoagulant effect in animal experiments. In hypercholesterolemic rabbits the cornelian cherry powder reduced the plasma fibrinogen level after feeding over 60 days. The results indicated that consumption of this dried plant material is likely to be beneficial in atherosclerotic patients due to its reducing effects on fibrinogen (Asgary et al., [@B7]; Rafieian-Kopaei et al., [@B143]). A significant decrease in the platelet distribution width (PDW) was found in male rats treated with 50, 200, and 400 mg/kg body weight of a hydromethanolic extract over 3 weeks. The changes in the platelet-related parameters suggested platelet activity inhibition without bone marrow suppression in the treated groups in comparison with the control groups. Regarding to the secondary products present in the drug, it is evidence that antioxidants reduce the platelet activity through stimulation of prostacyclin synthesis and scavenging the synthesis-inhibiting peroxides. Recent studies have shown that polyphenols such as quercetin (**66**) and catechin (**88**), stop NADPH oxidase enzyme (present in platelets). Therefore, inhibiting the production of superoxide anion (·$\text{O}_{2}^{-}$) and increasing the biological power of NO consequently regulate glycoprotein pine receptors (GPIIb-IIIa) on platelet membrane surface, that in turn inhibits platelets\' activation and their adherence during inflammation and thrombosis processes. Decreasing effect of the fruit extract on platelet activity might classify it as an alternative for antiplatelet therapy in cardiovascular diseases (Abdollahi et al., [@B2]). Unfortunately, clinical studies investigating this aspect of activity have not been published to date. Despite some similarities in the phytochemical composition regarding the phenolic compounds between fruits from *C. mas* and *C. officinalis* anticoagulant effects of *C. officinalis* preparations are not reported in the traditional Chinese medicine. According to the theoretical fundamentals of Chinese medicine the blood coagulation system did not play any role in TCM. Nevertheless, a biochemical study also proposed an antiplatelet activity of this drug based on malic acid (**171**), citric acid (**176**), and succinic acid (**177**) identified in the fruits of *C. officinalis* (Zhang Q. -A. et al., [@B203]).

### Ophthalmic activity

It is believed that anthocyanins as well as other antioxidants may improve the visual functions and the visual field of patients with normal-tension glaucoma via neuroprotective effect, inhibition of lipid peroxidation and improvement of vascular blood flow into the optic nerve. The progressive optic nerve damage accompanied by morphological changes, loss of the field of vision and even increased intraocular pressure are the symptoms of so called glaucoma. An interesting study on the effect of an anthocyanin-iridoid fraction derived from fruits of *C. mas* on intraocular pressure was conducted in rabbits. Intraocular pressure was decreased by 19 and 25% after 2--3 h intraconjunctival administration of the fraction or loganic acid (**3**) solution (0.7%), respectively (Szumny et al., [@B162]). This activity of cornelian cherries polyphenols is likely to provide beneficial effects on vascular flow in diabetic and hypertensive retinopathy.

*Cornus officinalis* Sieb. et Zucc.
-----------------------------------

### Antiosteoporotic activity

Osteoporosis as a chronic disease is closely related with aging processes in the elderly. Chinese herbal medicines have been used to treat this disease for a long time and among the preparations listed in Chinese Pharmacopoeia fruits of *C. officinalis* are also included (Huang et al., [@B71]). Based on the modern findings in pathogenesis and treatment of osteoporosis a variety of results from biochemical and cell biological experiments are published which support the idea that natural products present in the plant preparation play a beneficial role.

Extract of *C. officinalis* significantly inhibits RANKL-mediated osteoclast differentiation in a dose-dependent manner and RANKL-induced phosphorylation of p38 and c-JUN N-terminal kinase. In the same way, the protein expression of c-Fos and NFATc1 is also suppressed as well as the RANKL-induced degradation of IκB kinase (Kim J. Y. et al., [@B92]). Morroniside (**8**), one the main constituent of extracts from *C. officinalis* fruits, has been studied on osteoarthritis in human chondrocytes. This compound increased the levels of type II collagen, and aggrecan as well as improved the level of proteoglycans in cartilage matrix. In this manner, it supported the survival of chondrocytes with articular cartilage thickness (Cheng et al., [@B25]). Summarizing, the extracts of *C. officinalis* or individual compounds inhibit osteoclast differentiation not only in *in vitro* cellular models but also in osteoporosis animal models (Xia et al., [@B178]). Detailed animal studies or clinical trials are not published.

### Immunomodulatory activity

The pivotal characteristics of immunomodulators in the maintenance of the human well-being and health cannot be overlooked. The sources of these medicinal remedies are part of long traditions in different regions of the world, such as traditional Chinese medicine, which have been developed through empirical experience. Traditional medicine employs a holistic approach to the prevention of disease and traditional herbal medicines are a source of components with therapeutic value (Tiwari et al., [@B165]). Many studies have been conducted also on preparations of *C. officinalis* and have revealed constituents that influence the innate immune system through the stimulation of macrophages and lymphocytes, and modulation of the cytokine profile, which leads to a reduction of the incidence of infections or allergic diseases.

In addition, allergic asthma is a chronic inflammatory disease of the airways, demonstrated by symptoms such as wheezing, coughing, breathlessness, and airways inflammation. Investigations in a mouse model of allergic asthma suggest that the therapeutic effects of *Corni fructus* are mediated by reduced production of Th2 cytokines (IL-5), eotaxin, and specific IgE as well as a reduced eosinophil infiltration (Kim S. H. et al., [@B93]). These findings are supported by animal experiments with polysaccharides from crude and processed *C. officinalis* fruits which have an enhanced effect on non-specific immunity, specific humoral immunity and specific cellular immunity in immuno-depressed mice (Du et al., [@B43]).

Along with the anti-inflammatory effects mentioned before, these results provide some evidence that the fruits of *C. officinalis* show immune-protective activity. Nevertheless, the evidence by human studies is still missing.

### Insecticidal activity

An interesting biological activity is the insecticidal effect of 5-hydroxymethylfurfural (**163**) and dimethyl malate (**173**) determined in a bioassay-guided fractionation of methanolic extract from the fruits of *C. officinalis* against larvae of *D. melanogaster*. Acute toxicity against adults of *D. melanogaster* was determined showing LD50 value of 34.0 and 21.5 μg/adult for 5-hydroxymethylfurfural (**168**) and dimethyl malate (**173**), respectively (Miyazawa et al., [@B118]). Such investigations were reported rather infrequently. Nevertheless, they are important with respect to protect health and food quality in the past and presently. The use of such experiences could help to develop ecological strategies for modern food storage.

Conclusion {#s5}
==========

The utilization of plant resources for nutrition and medicinal use in the past belongs to the process of civilization. The investigation of such remarkable fruits from both species is therefore not surprising. According to the different ideas regarding the origin of diseases and methods for therapeutic treatment, the different use of fruits from *C. mas* und *C. officinalis* in the West and the East could be explained. Despite all these differences it is rather surprising that such a level of consistency is evident. The chemical composition of *C. mas* and *C. officinalis* seems to be well-established. However, the availability of missing information on some groups of compounds, such as fatty acids, carotenoids and ascorbic acid in the fruits of *C. officinalis*, is still needed. Nevertheless, fruits of both species are rich in iridoids, anthocyanins, and flavonoids. The main difference in phytochemicals concern tannins, which were found only in *C. officinalis* and may potentially determine the biological activity in a significant manner. However, the role of tannins, except for 7-*O*-galloyl-D-sedoheptulose, was not widely considered in the biological activity of *C. officinalis* fruits. Taking into consideration the close phylogenetic relationship of both species the question about tannins in fruits of *C. mas* is open. On the other hand, tannins do not rather occur in the iridoid-rich plant materials but this hypothesis requires detailed elucidation in this case. Nevertheless, the transfer of medicinal experiences from the West to the East or *vice versa* cannot be excluded but is not documented in the literature for this two species. The explanation for this consistency seems to be rather the result of testing and empirical observation. Analyzing the ethnopharmacological data available under modern scientific aspects and correlating the phytochemical composition of both species, the results show that nearly the same ingredients are also attributed for the same activity or presumed therapeutic use. However, some data concerning the phytochemical composition as well as pharmacological activity of, particularly *C. officinalis*, are still missed or limited due to their availability in Chinese. Thus, only dedicated comparative investigations of *C. mas* and *C. officinalis* fruit preparations could really provide evidence of similarities or differences in the field of their phytochemical composition and biological or pharmacological properties. Last but not least is the assignation of extracts constituents potentially responsible for the specific activity. It means that the accordance between ethnopharmacological use of both plant materials should be based on the well-established chemical composition as well as simultaneous *in vitro* and *in vivo* studies, which may facilitate the identification of active constituents. Only these studies could validate careful observations of the users or physicians in the past.
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